FluoroPharma

Healthcare 📍 Boston, United States 👥 11-50 employees 💰 $11.2M raised 📅 Founded 2003

FluoroPharma, Inc., a molecular imaging company, engages in the discovery, development, and commercialization of diagnostic imaging products for the positron emission tomography (PET) market. Its products include CardioPET, a modified fatty acid that provides insight into regions of metabolic insufficiency in myocardiu

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Debt

$11.2M

Founded

2003

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from FluoroPharma's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction